Target intelligence / Profile preview

Guanylate binding protein 1 pseudogene 1 (GBP1P1)

Target
GBP1P1
Molecular classification
Other (pseudogene), Long non-coding RNA
01

Overview

Guanylate binding protein 1 pseudogene 1 (GBP1P1), also known as LIMIT, is a pseudogene-derived long non-coding RNA located on human chromosome 1[1][2][3][4][5][6]. Despite being a non-coding RNA that does not produce a protein, GBP1P1 is transcribed and has been shown to play a functional role in regulating immune responses and viral replication, particularly in the context of influenza A virus infection, where it acts as a decoy that sequesters the RNA helicase DHX9, thereby inhibiting viral replication[2]. GBP1P1 is an interferon-inducible gene regulated by the JAK/STAT pathway[2]. High expression is observed in tissues such as the esophagus mucosa, lungs, and thyroid, and abnormal expression has been linked to diseases including various cancers, tuberculosis, and neurocysticercosis[2]. Unlike traditional protein-coding drug or therapeutic targets, GBP1P1 is not a receptor, enzyme, or transporter and is not currently recognized as a direct therapeutic target[2][6]. Its primary known role is as a regulator of gene expression in antiviral and possibly tumor immunity contexts.

Other names
LIMITlncRNA inducing MHC-I and immunogenicity of tumour
02

Biological functions

Immune responseRegulation of viral replicationRegulation of gene expression (non-coding RNA function)
03

Disease associations

CancerInfectionInflammation

Beyond the preview

Go deeper on Guanylate binding protein 1 pseudogene 1 (GBP1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanylate binding protein 1 pseudogene 1 (GBP1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call